The HepQuant CLIA-certified laboratory performs testing using serum samples from clinical trials driven by pharmaceutical companies and academic research centers. HepQuant has worked with over 23 leading pharmaceutical companies and research institutions across the spectrum of clinical trials, including MAFLD/MASH fibrosis and cirrhosis trials, viral hepatitis trials, biliary disease trials, alcoholic hepatitis trials, genetic-related trials, end-stage liver disease trials, and hepatic impairment trials. Please visit the Resources Page to read peer-reviewed papers and scientific posters.
HepQuant DuO™ is currently available for use in clinical trials. HepQuant DuO is a minimally invasive, blood-based test that quantifies liver function and portal system shunting and requires the ingestion of cholate followed by two blood draws over 60 minutes. The results from the test provide parameters of Portal and Systemic Filtrations rates (Portal HFR, Systemic HFR), Shunt Fraction, Disease Severity Index (DSI), and Hepatic Reserve (HR). To receive more information about HepQuant DuO, please click the CONTACT US link below.
Solutions for all Phases of Drug Development
HepQuant works with leading pharmaceutical companies in phase I, II, III, and IV clinical trials. Expertise we offer includes:
Expert Consultation
Analysis and assessments of research applications of HepQuant tests
Experienced Clinical Trials Management Team
Training, test kit supply and delivery management, site management, study-close out, and operational support
Experienced Lab and Compliant with COLA/CLIA Regulations
HepQuant’s laboratory is the sole provider and performs HepQuant’s proprietary testing
Data Analysis, Presentation & Publication Support
Our leading experts support clients in data modeling, presentation, and publication
Experienced Sites
HepQuant has supported and trained 100+ sites experienced with HepQuant technology
Global Site Initiative
Due to demand for HepQuant DuO testing in global trials, HepQuant has implemented initiatives to allow testing at sites globally
Strategic Collaboration and Partnering
HepQuant is pursuing initiatives with pharmaceutical companies. Please contact us for more information.
HepQuant DuO is a Laboratory Developed Test (LDT). This test was developed and its performance characteristics determined by HepQuant, LLC in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.